Clinical Trial NCT05389449

Trial

Alexion – ALXN2040-PNH-303

Clinical trial ID

NCT05389449

Drug name

ALXN2040, ACH- 0144471, Danicopan

Company:

Alexion

Drug trade name

Voydeya®

Phase of study

3

Current status

Active, not recruiting

Start

10/2022

Substance

Low molecular compound

Research question

LTE add on to C5i treatment in patients previously treatedwith danicopan

Delivery method of drug

Oral

Frequency

3 x daily

Clinical trial locations

UK USA Italy